Navigation Links
The Lilly TB Drug Discovery Initiative Begins Work on New Compounds to Fill Early-Stage TB Drug Pipeline
Date:10/7/2008

nto something more deadly than ever before. XDR-TB has now been found in almost 50 countries, including the U.S., England, Japan, Italy and Norway.

To fight the new strains, new drugs with more muscle are needed and, while a number of drugs are in later stages of clinical trial, this Initiative is needed to fill the early-stages pipeline.

"The emergence of drug resistant TB is of global consequence. While many organizations are investigating novel drugs and vaccines to minimize the burden of tuberculosis, clearly more work is required. Our contribution to this effort will be to leverage IDRI's internal capabilities, while leaning heavily on our public private-partnership with the Lilly Initiative," said Dr. Steve Reed, Founder and Head of IDRI's Research and Development Program.

The Lilly TB Drug Discovery Initiative's Board of Advisors includes Alex Azar and Dr. Gail Cassell from Lilly; Dr. Barry Bloom, Dean of Harvard University School of Public Health; Dr. Queta Bond, President of Burroughs Wellcome Fund (ret.); Dr. Bruce Carter, Liaison to the Board of Directors for the TB Alliance; Dr. Paul Farmer, Partners In Health and Harvard Medical School; Dr. Carole Heilman, Director of the Division of Microbiology and Infectious Diseases (DMID) at the NIAID; Dr. Regina Rabinovitch, Director of Infectious Diseases for the Bill and Melinda Gates Foundation and Dr. George Whitesides, Woodford L. and Ann A. Flowers University Professor at Harvard University. Dr. Steve Reed from IDRI will serve as the Chair and Dr. Barbara Laughon from NIAID will serve as the Executive Secretary.

About The Lilly TB Drug Discovery Initiative

The Lilly TB Drug Discovery Initiative is a not-for-profit public-private partnership with a mission to accelerate early-stage drug discovery by bringing together specialists from around the world for the systematic exploration of vast, private molecular libraries in search of new TB treatments. Headquartered in Seattle,
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Lilly to Acquire ImClone Systems in $6.5 Billion Transaction
2. Covance and Lilly Finalize 10-Year, $1.6 Billion Strategic R&D Collaboration
3. BioMS Medical announces receipt of milestone payment from Eli Lilly and Company
4. Amylin Pharmaceuticals and Eli Lilly Provide Context for FDA Alert for BYETTA
5. Amylin and Lilly Set Date and Time for Conference Call
6. Lilly Announces Completion of SGX Acquisition
7. SGX - Lilly Merger Offer Receives Positive Opinions From Proxy Advisory Firms
8. Lilly Reaffirms Purchase Offer for SGX Pharmaceuticals
9. Lilly Reports Solid Second-Quarter Results
10. Lilly to Acquire SGX Pharmaceuticals
11. Lillys Connelly Appointed to the Presidents Commission on White House Fellowships
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... ... July 07, 2015 , ... uBiome, the leading microbial genomics ... of microbiome sampling kits and full 16S laboratory analysis. The goal is to fast-track ... will also have access to their own dashboard, enabling them to view and compare ...
(Date:7/7/2015)... (PRWEB) , ... July 07, 2015 , ... ... membership driven community in the biometrical area. What began as a conference for ... global community for various functions in the biometrical area. Statistical Programmers, Data Managers ...
(Date:7/7/2015)... ... July 07, 2015 , ... Currently deployed ... was developed to solve many of the complex logistical and data management ... involve multiple clinical sites and/or remote data coordination centers. , CentrePoint drastically ...
(Date:7/6/2015)... ... July 06, 2015 , ... An optical ... reveal how blood flows in the brain during stroke, providing information that could ... new article published in the journal Neurophotonics describes work at the ...
Breaking Biology Technology:uBiome to Award Grant of up to $100k for Groundbreaking Microbiome Research 2uBiome to Award Grant of up to $100k for Groundbreaking Microbiome Research 3PhUSE Delighted to Welcome Member Number 5.000 2ActiGraph Launches CentrePoint Cloud-based Study Management Software Platform 2ActiGraph Launches CentrePoint Cloud-based Study Management Software Platform 3Reducing Stroke Damage May be Next Application for OCT Technology Now Widely Used in Eye and Vision Healthcare 2Reducing Stroke Damage May be Next Application for OCT Technology Now Widely Used in Eye and Vision Healthcare 3
... PDL BioPharma, Inc. (PDL, the Company) (NASDAQ: ... to market and other conditions, $135 million aggregate principal amount ... Company,s shelf registration statement filed with the U.S. Securities and ... expects to grant the underwriters a 13-day overallotment option to ...
... The U.S. Food and Drug Administration is requesting input ... of a user fee program for biosimilar and interchangeable ... http://photos.prnewswire.com/prnh/20090824/FDALOGO ) Biological products are produced in ... animal cell, while small molecule drugs are typically made ...
... May 9, 2011 Accuray Incorporated (Nasdaq: ... field of radiosurgery, announced today that the U.S. Securities ... S-4 Registration Statement relating to the previously announced acquisition ... in the registration statement will first be mailed to ...
Cached Biology Technology:PDL BioPharma, Inc. Announces Proposed $135 Million Public Offering of New Convertible Senior Notes Due 2015 2PDL BioPharma, Inc. Announces Proposed $135 Million Public Offering of New Convertible Senior Notes Due 2015 3PDL BioPharma, Inc. Announces Proposed $135 Million Public Offering of New Convertible Senior Notes Due 2015 4PDL BioPharma, Inc. Announces Proposed $135 Million Public Offering of New Convertible Senior Notes Due 2015 5FDA Requests Input on Development of User Fee Program for Biosimilar and Interchangeable Biological Products 2SEC Declares Accuray Form S-4 Registration Statement Effective in Proposed Acquisition of TomoTherapy 2SEC Declares Accuray Form S-4 Registration Statement Effective in Proposed Acquisition of TomoTherapy 3SEC Declares Accuray Form S-4 Registration Statement Effective in Proposed Acquisition of TomoTherapy 4
(Date:6/16/2015)... , June 16, 2015 /CNW Telbec/ - handyem ... centralized around the incorporation of handyem,s HPC-150 portable ... laboratory, the Mo-POD™. This unprecedented model of mobile ... Conference at the Pennsylvania ... June 15 th to 18 th ...
(Date:6/16/2015)... Fingerprint Cards (FPC) raises the revenue guidance for ... at least 340 MSEK to that it will amount to ... growth and orders received the revenue guidance for 2015 is ... will exceed 1,500 MSEK to an updated guidance that revenue ... Due to receipt of orders of touch fingerprint sensors with ...
(Date:6/15/2015)... Conn. , Jun. 15, 2015 NXT-ID, Inc. (NASDAQ: ... company focused on the growing mobile commerce market, announces that ... be showcased to media at Digital Experience! @ NYC June ... summer showcase of the latest innovation in technology to over ... will be held at the Metropolitan Pavilion in ...
Breaking Biology News(10 mins):handyem and FlowMetric Diagnostics announce their partnership in the development of Flow Cytometry- Based Solutions in diagnostic capabilities 2handyem and FlowMetric Diagnostics announce their partnership in the development of Flow Cytometry- Based Solutions in diagnostic capabilities 3Fingerprint Cards Raises the Revenue Guidance for Q2 2015 and for the Full Year 2015 2Fingerprint Cards Raises the Revenue Guidance for Q2 2015 and for the Full Year 2015 3Wocket Smart Wallet Exhibiting at Pepcom Digital Experience! @ NYC June 18th 2Wocket Smart Wallet Exhibiting at Pepcom Digital Experience! @ NYC June 18th 3
... who have high blood sugar before undergoing surgery ... deep vein thrombosis and even pulmonary embolism after ... anesthesiology in the Artificial Pancreas Center at Jefferson ... and his colleagues examined records of nearly 6,500 ...
... light on how tiny molecular motors that transport materials ... , The knowledge could lead to better understanding of ... such as Down syndrome caused by faulty molecular motors, ... researchers said. For example, molecular motors are responsible for ...
... Two Boston University biomedical engineers have won a ... continue groundbreaking research aimed at reducing the cost ... , Boston University Associate Professor of Biomedical Engineering ... chosen for the NIH's National Human Genome Research ...
Cached Biology News:Jefferson scientists find high glucose before surgery raises risk of dangerous complications 2Researchers image molecular motor structural changes 2Researchers image molecular motor structural changes 3Researchers image molecular motor structural changes 4Boston University biomedical engineers win major grant for pursuit of the '$1,000 Genome' 2
... ever faster, you need a partner who can ... constant focus is on providing tools and solutions ... Biomek 3000 Laboratory Automation Workstation offers a liquid ... flexible. By integrating all aspects of liquid handling ...
... MaxArray Rabbit Tissue Arrays contain 60 rabbit tissue ... package contains 4 unstained slides and 1 hematoxylin ... Each slide contains 15 different tissues from 4 ... samples per slide. Each tissue sample (or core) ...
... with a wide variety of purity levels, scales ... Purity: IG(>50%), >70%, >80% and ... Sequence Length: Up to 120 residues ... D-amino acids, MAPs, KLH/BSA conjugation, and much more. ...
... Antigen sequence: H-Ala-Cys-Asp-Thr-Ala-Thr-Cys-Val-Thr-His-Arg-Leu-Ala-Gly-Leu-Leu-Ser-Arg-Ser-Gly-Gly-Val-Val-Lys-Asn-Asn-Phe-Val-Pro-Thr-Asn-Val-Gly-Ser-Lys-Ala-Phe-NH 2 ... our corresponding peptide and ... 5 I-labelled peptide, ... (H-1470) and ([ 1 ...
Biology Products: